Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study-Reference-Cited by-同舟云学术

Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study

Published:2018-08-18 Issue:2 Volume:23 Page:207-214
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Katsuno Takayuki,Masuda Tomohiro,Saito Shoji,Kato Noritoshi,Ishimoto Takuji,Kato Sawako,Kosugi Tomoki,Tsuboi Naotake,Kitamura Hiroshi,Tsuzuki Toyonori,Ito Yasuhiko,Maruyama Shoichi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/article/10.1007/s10157-018-1630-y/fulltext.html

Reference24 articles.

1. Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis. 1991;17:687–92.

2. Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39:503–12.

3. Sato M, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term outcomes of initial therapy for idiopathic membranous nephropathy. Clin Exp Nephrol. 2017;21:842–51.

4. Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, et al. Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol. 2012;23:1416–25.

5. Katsuno T, Ozaki T, Kim H, Kato N, Suzuki Y, Akiyama S, et al. Single-dose rituximab therapy for refractory idiopathic membranous nephropathy: a single-center experience. Intern Med. 2017;56:1679–86.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis;PLOS ONE;2024-07-31

2. Histological transition from minimal change disease to THSD7A-associated membranous nephropathy in a patient receiving long-term steroid treatment: A case report;Medicine;2023-10-13

3. Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis;Glomerular Diseases;2023-08-18

4. Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?;Journal of Clinical Medicine;2021-12-13

5. Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis;Drug Design, Development and Therapy;2021-05